Profitability, third-party reimbursement, and access to community pharmacies

Clinical Therapeutics

Volumn 18, Issue 4, 1996, Pages 703-715

  Carroll, Norman V ^a   Miederhoff, Patrick A ^a   Waters, Lawrence W ^b  

^a VIRGINIA COMMONWEALTH UNIVERSITY   (United States)

^b Revco DS   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; COMMUNITY MEDICINE; PHARMACY; PRESCRIPTION; PROFIT; REGRESSION ANALYSIS; REIMBURSEMENT; UNITED STATES;

EID: 0029745169     PISSN: 01492918     EISSN: 1879114X     Source Type: Journal    
DOI: 10.1016/S0149-2918(96)80221-9     Document Type: Article

References (31)

1. Senter DS. Prescription trends survey. Am Drug. 1994;201:23-26.
2. Anonymous. 1995 Prescription trends survey. Am Drug. 1995;212:23-26.
3. IMS Class-of-Trade Analysis: 1995. Totowa, NJ: IMS America; 1996:1-20.
4. Watkins B. Managed care comes to prescription drugs: Changing channels. Bus Health. 1995;Special Report: 15-18.
5. Wentz WH. One lawyer's view of discriminatory pricing. Am Pharm. 1994; NS34:25-27, 42.
6. Flanagan ME. Discriminatory pricing law-suits could change future of community pharmacy. Am Pharm. 1994;NS34:20-24.
7. Anonymous. Slowdown continues in Rx dept gains; number dispensed increases by less than 1%. Am Drug. 1986;193:80-84.
8. Anonymous. Third-party payors cover 45.1% of $57.2 bil. retail rx market. Weekly Pharmacy Reports: The Green Sheet. 1995;44:2.
9. Hargis JR, ed. Lilly Digest 1992: Survey of 1991 Operational Data. 60th ed. Indianapolis, Ind: Eli Lilly and Company; 1992.
10. Geesman G, Huffman DC Jr, eds. NARD-Lilly Digest 1994: Survey of 1993 Operational Data. 62nd ed. Indianapolis, Ind: Eli Lilly and Company; 1995.
11. Anonymous. 1994 Annual Report: Fay's Incorporated. Liverpool, NY: Fay's Incorporated; 1994.
12. Anonymous. 1994 Annual Report: Rite Aid Corporation. Harrisburg, Pa: Rite Aid Corporation; 1994.
13. Anonymous. Annual Report 1994: Revco DS, Inc. Twinsburg, Ohio: Revco DS, Inc; 1994.
14. Anonymous. Walgreen's Annual Report 1994. Deerfield, Ill: Walgreen Co; 1994.
15. Harris N. Pharmacists rate managed care plans. Am Drug. 1995;211:24-26.
16. Muirhead G. Riding the tide of managed care. Drug Top. 1994;138:41-54.
17. Carroll NV. Cost of dispensing private-pay and third-party prescriptions in independent pharmacies. J Res Pharm Econ. 1991;3:3-16.
18. Schafermeyer KW, Thomas J III, Schondelmeyer SW. An assessment of chain pharmacies' costs of dispensing a third party prescription - final report. Lafayette, Ind: Pharmaceutical Economics Research Center; 1990.
19. Carroll NV. Demographic and prescription patronage motive differences among segments in the community pharmacy market. J Pharm Market Manage. 1987; 1:19-33.
20. Lipowski EE. Predictor of community pharmacy preference: A logistic regression analysis of consumers' socioeconomic and shopping characteristics. J Pharm Market Manage. 1991;6:43-61.
21. Smith HA, Coons SJ. Patronage factors and consumer satisfaction with sources of prescription purchases. J Pharm Market Manage. 1990;4:61-81.
22. US Department of Commerce. 1987 Census of Retail Trade. Geographic Area Series, Virginia. Washington, DC: US Government Printing Office; 1989.
23. Anonymous. Virginia Statistical Abstract. Charlottesville, Va: Center for Public Service; 1995.
24. Kirking DM, Ascione FJ, Richards JW. Choices in prescription-drug benefit programs: Mail versus community pharmacy services. Milbank Q. 1990;68:29-51.
25. Horgan C, Goody B, Knapp D, et al. The role of mail service pharmacies. Health Aff. 1990;9:66-74.
26. Enright SM. Mail-order pharmaceuticals. Am J Hosp Pharm. 1987;44:1870-1873.
27. Curtiss FR. Managed health care. Am J Hosp Pharm. 1989;46:742-763.
28. Curtiss FR. Managed care: The second generation. Am J Hosp Pharm. 1990;47: 2047-2052.
29. Anderson L, Ellwood P, Marcrom R, et al, eds. Opportunities for the Community Pharmacist in Managed Care. Special Report. Washington, DC: American Pharmaceutical Association; 1994.
30. Anonymous. Into the sunset. NARD Journal. 1995;117:27-34.
31. Schwartz RM. Medicaid fee cuts? Am Drug. 1994;211:8-9.